Skip to main content
logo
Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
3.280
+0.050 (1.55%)
Oct 2, 2026, 4:00 PM EDT - Market closed

Minerva Neurosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1571741643834
Market Cap Growth
965.39%1019.70%-63.88%406.53%-75.19%-65.73%
Enterprise Value
14122249764033
Last Close Price
3.284.022.226.151.596.41

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--10.80---
PB Ratio
--1.28-0.60-1.51-0.424.29

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.30-0.44-2.33-2.88-3.688.32
Net Debt / Equity Ratio
0.080.16-1.50-1.44-1.880.70
Net Debt / EBITDA Ratio
0.541.48-1.77-1.78--0.18
Net Debt / FCF Ratio
0.581.65-1.98-2.78-1.53-0.23
Quick Ratio
19.0235.937.5312.2528.4621.55
Current Ratio
20.1436.287.8512.5729.1522.07
Return on Equity (ROE)
------164.60%
Return on Assets (ROA)
-28.42%-13.97%-29.04%-25.81%-23.86%-27.98%
Return on Capital Employed (ROCE)
-31.30%-15.80%-63.70%-43.20%-47.00%-40.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-251.80%-168.67%9.26%-69.77%-378.15%-145.84%
FCF Yield
-16.71%-7.77%-125.84%-34.38%-290.45%-71.89%
Buyback Yield / Dilution
-260.56%-11.75%-16.41%-21.84%0.00%-4.41%
SEC Filings: 10-K · 10-Q